KEYTRUDA KIDNEY FAILURE FUNDAMENTALS EXPLAINED

This prevents the activation in the T-cell which Generally would target and destroy cancer. The cancer cells can then multiply and spread. When Keytruda binds for the PD-1 receptor it stops cancer cells from linking to and inactivating T-cells, permitting T-cell re-activation, and boosting the immune system's response against cancer. This affects t